BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 17044048)

  • 1. Neuroblastoma tumors with favorable and unfavorable outcomes: Significant differences in mRNA expression of genes mapped at 1p36.2.
    Fransson S; Martinsson T; Ejeskär K
    Genes Chromosomes Cancer; 2007 Jan; 46(1):45-52. PubMed ID: 17044048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Definition and characterization of a region of 1p36.3 consistently deleted in neuroblastoma.
    White PS; Thompson PM; Gotoh T; Okawa ER; Igarashi J; Kok M; Winter C; Gregory SG; Hogarty MD; Maris JM; Brodeur GM
    Oncogene; 2005 Apr; 24(16):2684-94. PubMed ID: 15829979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of genomic imprinting at 1p35-36 in neuroblastoma.
    Hogarty MD; Maris JM; White PS; Guo C; Brodeur GM
    Med Pediatr Oncol; 2001 Jan; 36(1):52-5. PubMed ID: 11464906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion of chromosome 1p loci and microsatellite instability in neuroblastomas analyzed with short-tandem repeat polymorphisms.
    Martinsson T; Sjöberg RM; Hedborg F; Kogner P
    Cancer Res; 1995 Dec; 55(23):5681-6. PubMed ID: 7585654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Introduction of in vitro transcribed ENO1 mRNA into neuroblastoma cells induces cell death.
    Ejeskär K; Krona C; Carén H; Zaibak F; Li L; Martinsson T; Ioannou PA
    BMC Cancer; 2005 Dec; 5():161. PubMed ID: 16359544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detailed molecular analysis of 1p36 in neuroblastoma.
    White PS; Thompson PM; Seifried BA; Sulman EP; Jensen SJ; Guo C; Maris JM; Hogarty MD; Allen C; Biegel JA; Matise TC; Gregory SG; Reynolds CP; Brodeur GM
    Med Pediatr Oncol; 2001 Jan; 36(1):37-41. PubMed ID: 11464901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cluster of genes located in 1p36 are down-regulated in neuroblastomas with poor prognosis, but not due to CpG island methylation.
    Carén H; Ejeskär K; Fransson S; Hesson L; Latif F; Sjöberg RM; Krona C; Martinsson T
    Mol Cancer; 2005 Mar; 4(1):10. PubMed ID: 15740626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and sequence analysis of candidates for the 1p36.31 tumor suppressor gene deleted in neuroblastomas.
    Okawa ER; Gotoh T; Manne J; Igarashi J; Fujita T; Silverman KA; Xhao H; Mosse YP; White PS; Brodeur GM
    Oncogene; 2008 Jan; 27(6):803-10. PubMed ID: 17667943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological characteristics of neuroblastoma with partial deletion in the short arm of chromosome 1.
    Hiyama E; Hiyama K; Ohtsu K; Yamaoka H; Fukuba I; Matsuura Y; Yokoyama T
    Med Pediatr Oncol; 2001 Jan; 36(1):67-74. PubMed ID: 11464909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression profiling of 1p35-36 genes in neuroblastoma.
    Janoueix-Lerosey I; Novikov E; Monteiro M; Gruel N; Schleiermacher G; Loriod B; Nguyen C; Delattre O
    Oncogene; 2004 Aug; 23(35):5912-22. PubMed ID: 15195138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smallest region of overlapping deletion in 1p36 in human neuroblastoma: a 1 Mbp cosmid and PAC contig.
    Bauer A; Savelyeva L; Claas A; Praml C; Berthold F; Schwab M
    Genes Chromosomes Cancer; 2001 Jul; 31(3):228-39. PubMed ID: 11391793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive analysis of chromosome 1p deletions in neuroblastoma.
    Maris JM; Guo C; Blake D; White PS; Hogarty MD; Thompson PM; Rajalingam V; Gerbing R; Stram DO; Matthay KK; Seeger RC; Brodeur GM
    Med Pediatr Oncol; 2001 Jan; 36(1):32-6. PubMed ID: 11464900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fine mapping of a tumour suppressor candidate gene region in 1p36.2-3, commonly deleted in neuroblastomas and germ cell tumours.
    Ejeskär K; Sjöberg RM; Abel F; Kogner P; Ambros PF; Martinsson T
    Med Pediatr Oncol; 2001 Jan; 36(1):61-6. PubMed ID: 11464908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrative genomics identifies distinct molecular classes of neuroblastoma and shows that multiple genes are targeted by regional alterations in DNA copy number.
    Wang Q; Diskin S; Rappaport E; Attiyeh E; Mosse Y; Shue D; Seiser E; Jagannathan J; Shusterman S; Bansal M; Khazi D; Winter C; Okawa E; Grant G; Cnaan A; Zhao H; Cheung NK; Gerald W; London W; Matthay KK; Brodeur GM; Maris JM
    Cancer Res; 2006 Jun; 66(12):6050-62. PubMed ID: 16778177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three chromosomal rearrangements in neuroblastoma cluster within a 300-kb region on 1p36.1.
    Spieker N; Beitsma M; Van Sluis P; Chan A; Caron H; Versteeg R
    Genes Chromosomes Cancer; 2001 Jun; 31(2):172-81. PubMed ID: 11319804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletion mapping in neuroblastoma cell lines suggests two distinct tumor suppressor genes in the 1p35-36 region, only one of which is associated with N-myc amplification.
    Cheng NC; Van Roy N; Chan A; Beitsma M; Westerveld A; Speleman F; Versteeg R
    Oncogene; 1995 Jan; 10(2):291-7. PubMed ID: 7838528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An integrated 5-Mb physical, genetic, and radiation hybrid map of a 1p36.1 region implicated in neuroblastoma pathogenesis.
    Spieker N; Beitsma M; van Sluis P; Roobeek I; den Dunnen JT; Speleman F; Caron H; Versteeg R
    Genes Chromosomes Cancer; 2000 Feb; 27(2):143-52. PubMed ID: 10612802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuated expression of DFFB is a hallmark of oligodendrogliomas with 1p-allelic loss.
    McDonald JM; Dunmire V; Taylor E; Sawaya R; Bruner J; Fuller GN; Aldape K; Zhang W
    Mol Cancer; 2005 Sep; 4():35. PubMed ID: 16156899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced expression of CAMTA1 correlates with adverse outcome in neuroblastoma patients.
    Henrich KO; Fischer M; Mertens D; Benner A; Wiedemeyer R; Brors B; Oberthuer A; Berthold F; Wei JS; Khan J; Schwab M; Westermann F
    Clin Cancer Res; 2006 Jan; 12(1):131-8. PubMed ID: 16397034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells.
    Welch C; Chen Y; Stallings RL
    Oncogene; 2007 Jul; 26(34):5017-22. PubMed ID: 17297439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.